Clinical trial dosage results summary The dosage charts above are not arbitrary
Learn about ergothioneine and its potential use for cognitive impairment, dementia, Alzheimer's disease, Parkinson's disease, cataract, or kidney disease, as well as its safety and cost of supplements containing this ingredient
[ \- Link Opens in New Tab]( Sheffler, Z
Hydroxocobalamin is the preferred agent in this patient population (see separate monograph in Less Common Drugs)
Topical Copper Peptides Affects surface layers of skin only Limited penetration through skin barrier Localized effect only where applied Good for maintenance, not transformation No systemic anti-aging benefit Available over-the-counter Injectable GHK-Cu Full systemic delivery to all tissues Reaches dermis, follicles, and healing sites Whole-body anti-aging effect More potent collagen stimulation Gene expression modulation (4,000+ genes) Requires medical prescription They are not mutually exclusive